"Molecular Therapy for Renal Diseases."

According to the authors' abstract of an article published in American Journal of Kidney Diseases, "The introduction of molecular therapy through the delivery of nucleic acids either as oligonucleotides or genetic constructs holds enormous promise for the treatment of renal disease. Significant barriers remain, however, before successful organ-specific molecular therapy can be applied to the kidney. These include the development of methods to target the kidney selectively, the definition of vectors that transduce renal tissue, the identification of appropriate molecular targets, the development of constructs that are regulated and expressed for long periods of time, the demonstration of...

Want to see the full article?

• Purchase this article for only $3.00